A 52-year-old man with newly diagnosed acute myeloid leukemia (AML) is being considered for induction chemotherapy. The treatment strategy aims to trigger apoptosis in leukemic blasts via the intrinsic (mitochondrial) pathway. Which of the following drugs is the drug of choice for inducing apoptosis through BCL-2 inhibition in AML?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.